Hoppa till innehållet

Antimicrobial Stewardship Outcomes in University Hospitals

Systematic optimization of antimicrobial stewardship programs within university hospitals constitutes a vital clinical necessity for curtailing resistant pathogens and safeguarding therapeutic efficacy. Interdisciplinary coordination among infectious disease physicians, clinical pharmacists, and microbiologists serves as the primary mechanism governing institutional prescribing behaviors, diagnostic fidelity, and patient safety. Strategic alignment of prospective audit feedback, formulary controls, and institutional policy provides a viable framework for mitigating healthcare expenditures while sustaining clinical excellence.

Arbetets mål

To evaluate antimicrobial stewardship outcomes in university hospitals by synthesizing clinical, microbiological, and economic determinants across tertiary academic settings.

Metodik

Comparative systematic synthesis and thematic analysis of peer-reviewed clinical studies, institutional stewardship reports, and hospital outcome databases.

Vetenskaplig nyhet

Identifies structural and interprofessional determinants mediating stewardship efficacy specifically within high-acuity university hospital environments.

Förhandsvisning av dokument

Granska formateringen och inledningen. Fullversionen anpassar strukturen efter standarden för den valda dokumenttypen.

PhD Dissertation

Degree:
Antimicrobial Stewardship Outcomes in University Hospitals

Author:

Group

First M. Last

Advisor:

Dr. First Last

City, 2026

Contents

Abstract
Sammanfattning
List of Publications
Chapter 1. Introduction and Problem Orientation
1.1 Clinical and Economic Burden of Antimicrobial Resistance
1.2 Institutional Context of Academic Medical Centers
1.3 Research Aims and Theoretical Grounding
Chapter 2. Theoretical Perspectives on Institutional Stewardship
2.1 Multidisciplinary Models in Antimicrobial Optimization
2.2 Behavioral and Organizational Factors in Prescriber Compliance
2.3 Diagnostic Stewardship and Laboratory Integration
2.4 Structural Barriers and Interprofessional Dynamics
Chapter 3. Methodological Framework for Outcome Evaluation
3.1 Synthesis Design and Secondary Document Selection Criteria
3.2 Classification of Clinical, Microbiological, and Economic Metrics
3.3 Comparative Assessment of Front-End versus Back-End Strategies
3.4 Methodological Validity, Bias, and Synthesis Constraints
Chapter 4. Evaluation of Clinical and Microbiological Outcomes
4.1 Reduction in Pathogen Resistance Patterns and Treatment Failures
4.2 Impact on Patient Mortality and Length of Inpatient Stay
4.3 Adverse Event Mitigation and Clostridioides difficile Rates
4.4 Specialty Ward Dynamics and Intensive Care Outcomes
Chapter 5. Institutional and Health Economic Dimensions
5.1 Cost-Utility and Direct Pharmacy Expenditure Variations
5.2 Resource Allocation and Clinical Pharmacy Staffing Models
5.3 Digital Surveillance and Information Technology Enablement
Chapter 6. Discussion and Strategic Synthesis
6.1 Integrative Analysis of University Hospital Stewardship Disparities
6.2 Policy Formulations and Educational Intervention Pathways
6.3 Limitations of the Current Body of Evidence
7.1 Summary of Key Theoretical and Applied Contributions
7.2 Directions for Longitudinal and Multi-Center Evaluation
Chapter 7. Conclusions and Future Research Directions
Bibliography

Introduction

The escalation of antimicrobial resistance poses a major clinical threat that compromises modern healthcare delivery across tertiary healthcare institutions globally [3]. In tertiary academic medical centers, complex patient morbidity, extensive intensive care utilization, and the empirical deployment of broad-spectrum therapies accelerate the emergence of multi-drug resistant pathogens [1]. Antimicrobial stewardship programs function as structured organizational interventions designed to optimize therapeutic regimens, slow resistance emergence, and reduce avoidable adverse patient outcomes [4]. Systematic investigation into institutional stewardship outcomes remains imperative for clarifying how academic hospital environments influence prescribing adherence and therapeutic efficacy [2]. Inappropriate antimicrobial utilization within tertiary academic environments frequently stems from systemic factors, including decentralized decision-making cultures, complex clinical hierarchies, and disparities in structural resource allocation [2]. Although multidisciplinary stewardship teams incorporate clinical pharmacists, microbiologists, and infectious disease specialists, institutional outcomes vary considerably depending on strategy selection and technological support [4, 5]. Diagnostic stewardship protocols and prospective audit systems demonstrate capacity to moderate excessive therapy, yet operational hurdles often constrain long-term clinical efficacy and institutional scalability [6, 7]. Evaluating the comparative effectiveness of front-end restrictions and back-end audit systems resolves crucial uncertainties regarding institutional program sustainability [4]. This doctoral dissertation establishes a rigorous conceptual and comparative synthesis to examine antimicrobial stewardship outcomes in university hospitals, identifying structural determinants that govern clinical and economic success [1, 4]. Utilizing a comparative evaluative design across secondary empirical literature and institutional reports, the investigation categorizes the interplay between multidisciplinary staffing, diagnostic integration, and prescriber adherence [4, 5]. The findings deliver verifiable theoretical clarity and strategic guidance for tertiary clinical leadership, reinforcing sustainable antimicrobial governance across complex university hospital infrastructures [2, 3].

3.3 Comparative Assessment of Front-End versus Back-End Strategies

Evaluating the comparative effectiveness of institutional interventions requires a structured methodological framework that categorizes stewardship mechanisms into proactive front-end controls and reactive back-end evaluations. Front-end strategies rely on formulary restriction and pre-authorization protocols to regulate antimicrobial prescribing prior to drug dispensation, whereas back-end strategies utilize prospective audit and feedback alongside post-prescription review to optimize therapeutic regimens across inpatient departments (Antimicrobial Stewardship Programs, 2024). In academic medical centers, methodological assessment must account for structural variability across clinical departments, as institutional context and interprofessional communication significantly influence programmatic efficacy across inpatient wards (Antimicrobial Resistance and Antimicrobial Stewardship, 2023). To ensure analytical rigor and internal validity, this synthesis operationalizes a multi-tiered outcome classification schema that measures clinical endpoints, microbiological resistance patterns, and healthcare resource utilization. Methodological evaluation of prospective audit and feedback demonstrates that direct clinician engagement facilitates sustained behavioral change while preserving prescriber autonomy across complex hospital settings (Antimicrobial Stewardship Programs, 2024). Furthermore, evaluating stewardship initiatives in university hospital environments requires systematic tracking of administrative support, multidisciplinary team composition, and dedicated educational pathways, which collectively mitigate clinical treatment failures (Implementation of an Antimicrobial Stewardship Program, 2026) and curb resistant pathogen proliferation across diverse wards (Antimicrobial Resistance and Antimicrobial Stewardship, 2023). Standardizing these evaluative criteria across heterogeneous hospital settings allows health researchers to isolate the specific therapeutic contributions of multidisciplinary stewardship teams, laboratory diagnostic integration, and institutional policy enforcement without conflating concurrent infection control practices.

References

  1. The Relationship between Antimicrobial Resistance and Patient Outcomes: Mortality, Length of Hospital Stay, and Health Care Costs
    Sara E. Cosgrove
    DOI-länk
  2. Antimicrobial resistance and antimicrobial stewardship in South Africa: a survey of healthcare workers in academic and nonacademic hospitals
    Kessendri Reddy, Yogandree Ramsamy, Khine Swe Swe-Han et al.
    DOI-länk
  3. Implementation of an antimicrobial stewardship program in Alexandria University Children's Hospital: an interventional study.
    Sarah Elsayed Saad Refaei, Laila El-Attar, Amira Ezzat Khamis Amine et al.
    DOI-länk
  4. Antimicrobial Stewardship Programs (AMSPs): Navigating Towards Optimal Antibiotic Use and Combating Antimicrobial Resistance
    Riti Kapoor, Diksha Sood, Kamal Kant Kalia et al.
  5. Pharmacists’ role in antimicrobial stewardship and relationship with antibiotic consumption in hospitals: An observational multicentre study
    Clément Ourghanlian, Nathanaël Lapidus, Marie Antignac et al.
  6. A new software to help optimize regional antimicrobial stewardship policy? Results from a two year-survey of antibiotic consumption and antimicrobial resistance in five hospitals in South-Eastern France
    Florence Lieutier-Colas
  7. Impact of a cerebrospinal fluid diagnostic stewardship intervention on quantity of tests, length of stay, antibiotic prescriptions, and cost
    Aaron Pathak, Sabra Shay, Todd Lasco et al.
  8. Antimicrobial Stewardship
    L. Hsieh, A. Amin

Lägg till en litteraturlista till arbetet

Verifierade källorFormateringsstandarderHög unicitetPro-modeller
Launch Offer -25%

Avhandling

Harvard (Swedish variant)

24 €31 €
  • 120–180 sidor.
  • Hög originalitet
  • Exportera till Word
  • Korrekt formatering
  • Offentlig förhandsvisning
    En förhandsvisning av en anderer författare kan inte göras privat. Ditt arbete kommer att vara privat och helt unikt.
  • Källförteckning (100+, Harvard)
    +1 €
  • Add alternative sources (News, .gov, .edu)

Avhandling

Harvard (Swedish variant)